HistoGenetics

HistoGenetics is a global leader in high-resolution Human Leukocyte Antigen (HLA) typing, providing essential immunogenetics services for transplantation and personalized medicine. The company utilizes proprietary high-throughput Next-Generation Sequencing (NGS) and bioinformatics pipelines to deliver precise genetic data for donor registries, transplant centers, and pharmaceutical researchers. Founded in 2005, HistoGenetics has processed millions of samples, significantly advancing the field of histocompatibility. In 2021, the company was acquired by CareDx for $250 million to integrate its sequencing expertise into a comprehensive transplant care platform. The laboratory is CLIA-certified and CAP-accredited, maintaining the highest standards for clinical diagnostic testing.